DigiStorm 2018 – 2
Saturday, February 21, 2026
21.7
C
Bengaluru
Hot topics
5 L&D Megatrends
2017 Learning and Development Special Issue. Articles by K. Hariram, Diksha Fouzdar and Vivek Hattangadi.
Interview with Ajit Singh, Chairman, ACG
Special interview with the Chairman of ACG and an invitation to "Pharmaceutical Marketing in the New Age" - a conference presented by ACG in partnership with MedicinMan
Digital Therapeutics: New Frontiers in Healthcare
“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale”
- Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi
American Tariffs and The Rise of the Corporate Superpower
From Nation-States to Corporate Titans: How Innovation is Redrawing...
Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025
1. Market Overview
The oncology sector remains the most dominant...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
Hot topics
Digital as Emergent Strategy – Lessons for Pharma from Honda
The door to the magical realm is open! Are...
When Influence Meets Accountability: Why India Wants Wellness Gurus to Show Their Credentials
India’s wellness economy is booming—nutraceuticals, supplements, and alternative therapies...
Pharma Marketing & The Reinvention
Introducing the top 10 companies in top 10 therapy areas according to statistics published by AIOCD
Don’t Do Digital for the Sake of Doing Digital
Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness.
The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
Newsletter
Get important news delivered directly to your inbox and stay connected!